The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1122
January 21, 2002
View Complete Issue         Table of Contents 2019 
Ortho Evra - A Contraceptive Patch
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Ortho Evra - A Contraceptive Patch
January 21, 2002 (Issue: 1122)
A transdermal contraceptive patch (Ortho Evra — Ortho-McNeil) has been approved by the FDA. Each 20 cm2 patch contains 6 mg of the progestin norelgestromin (the active metabolite of norgestimate) and 0.75 mg of ethinyl...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Ortho Evra - A Contraceptive Patch
Article code: 1122c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.